Author: Early Investing

Early Investing’s mission is to help its readers find the most promising investment opportunities outside the stock market. Our research is focused on two areas in particular: private startups and cryptocurrencies. We provide both educational material and recommendations on specific investments. With more than 140,000 readers and 40,000 subscribers, Early Investing is a leading destination for guidance in the alternative investment space.

Subscribe to Early's feed.

Premium

Startup Insider: How Startups Go Public

For startup investors, a company going public is the holy grail. That’s when the relatively small amount of money they invested into a young company turns into (hopefully) big bucks. There are three paths startups can take to going public — initial public offerings (IPOs), direct listings and special purpose acquisition companies (SPACs). Andy Gordon and Vin Narayanan assess the strengths and weaknesses of each one of these paths in this week’s Startup Insider.  …

Startup Insider: Medical Testing’s Golden Age

By Early Investing on April 21, 2021

We have a special treat for you this week. Our First Stage Investor members (click here to sign up) regularly get to hear Andy Gordon and Vin Narayanan interview founders. This week, we’re releasing a very special interview…
Premium

The Most Interesting Person in Startups: Buck Jordan

By Early Investing on March 22, 2021

Some of you may remember the Dos Equis Most Interesting Man in the World TV commercials. Buck Jordan, the CEO and founder of Wavemaker Labs, is the startup equivalent of the Most Interesting Man in the World. And Andy Gordon and Vin Narayanan interviewed him Friday for this…
Premium

Startup Insider: Equity Crowdfunding vs. Venture Capitalism

By Early Investing on March 15, 2021

Equity crowdfunding and venture capitalism share some similarities. But they’re also fundamentally different ways to invest. So it’s important to understand how they’re different. That way, investors can make the right decision when they’re crowdfunding a startup. In this week’s Startup Insider,…
Premium

Startup Insider: Why CityZenith Is Hosting its Own Raise

By Early Investing on March 11, 2021

Andy Gordon first recommended CityZenith as an investment opportunity at a $20M valuation in the summer of 2019. He recommended them again this past September at a $27.4 million valuation. CityZenith briefly paused that raise (watch this week’s…
Premium

Startup Insider: Learn About Biotech Startups from Insiders

By Early Investing on March 1, 2021

If you’ve ever wanted to understand how really smart founders think — or how biotech startups operate — then this episode of Startup Insider is for you. Monogram Orthopaedics’ co-founders Ben Sexson and Dr. Doug Unis joined Andy Gordon and Vin Narayanan for a wide-ranging conversation about their…
Premium

Startup Insider: Vipin Jain on Star Trek and Food Robotics

By Early Investing on February 22, 2021

When you build an incredible food robot and your first two big customers are Walmart and Jamba Juice, you’re doing something right. That’s why we invited Blendid co-founder Vipin Jain to join us on First Stage Investor’s Startup Insider to discuss what his food robot does, how it…
Premium

Startup Insider: Demystifying Funding Risk

By Early Investing on February 8, 2021

The savviest startup investors know that the difference between being mildly successful and being wildly successful comes down to understanding risk. Because when you’re investing in companies with a limited operating history, some risks are worth taking. Others are not. Not all risks are created equal…
Premium

Startup Insider: Assessing CPG Startups

By Early Investing on January 25, 2021

Two weeks ago on First Stage Investor‘s Startup Insider, Andy Gordon and Vin Narayanan discussed how to evaluate biotech and pharmaceutical startups. In this week’s Startup Insider, Andy and Vin explore the different factors people need to consider before…
Premium

Startup Insider: Making Smart Biotech Investments

By Early Investing on January 11, 2021

Seed stage investing in pharma and biotech companies is a little different than seed stage investing in other sectors. When pharma and biotech companies approach crowdfunders, they’re usually pre-clinical — which means that human trials haven’t begun yet. And they’re raising amounts of money that can’t possibly sustain…
Premium

Crypto Monitor: Crypto Market Forecast

By Early Investing on January 8, 2021

Crypto is rolling. Bitcoin cracked the $40,000 mark yesterday. Ethereum is up more than 800% in the last 365 days and nearing its all-time high. And Haven Protocol is up 144% since we first recommended it. So what’s driving the market? Where does the crypto market go next?…
Premium

Startup Insider: Crowdfunders Poised to Beat VCs

By Early Investing on January 4, 2021

2021 is here and the startup investing landscape is changing! This year, the limit on how much a startup can raise through crowdfunding increases from $1.07 million to $5 million. That’s great news for investors like us. And venture capitalists (VCs) don’t know…
Premium

Exclusive Crypto Update: The 2020 Crypto Surge

By Early Investing on December 3, 2020

The crypto markets are surging. Bitcoin is trading at more than $19,000. And the First Stage Investor crypto portfolio is in terrific shape. Monero is up 72% since we recommended it. Litecoin is up 82%. Ethereum is up 107%. Bitcoin is up 466%.
Premium

Startup Insider: Post-Pandemic Trends

By Early Investing on November 30, 2020

We finally have some good news on the COVID-19 front! It looks like the FDA will approve two vaccines shortly. And that by May or June of next year, we will start getting back to “normal.” So what does normal mean for startup investors? Which consumer…

Exclusive Video: Bitcoin and the Crypto Market

By Early Investing on November 24, 2020

Bitcoin cracked the $18,000 mark last week. And it’s primed to hit new all-time highs in the near future. So Andy Gordon and Vin Narayanan dusted off their crypto crystal ball for this special video. They let you know (among other things): How long the bull…
Premium

Startup Insider: An Update from Winc’s Founders

By Early Investing on November 23, 2020

Winc is one of our favorite startups in the First Stage Investor portfolio. Winc is combining big data and a really smart supply chain to disrupt the way wine is made and sold. And since we recommended them right…